Cutting Through Comorbidities: Clearing the Way to Appropriate Anticoagulant Therapy in Patients at Risk for Deep Vein Thrombosis and Pulmonary EmbolismPremiere Date: Tuesday, June 22, 2021
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, June 22, 2022
Note: Credit Is No Longer Available
|Gregory Piazza, MD, MS (Moderator)
Director, Vascular Medicine Section
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
|Geoffrey Barnes, MD, MSc
Assistant Professor, Cardiovascular Medicine and Vascular Medicine
Department of Internal Medicine, Division of Cardiovascular Medicine
University of Michigan Health System
Ann Arbor, MI
Venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and pulmonary embolism (PE) and affects up to 900,000 individuals in the U.S. each year, leading to nearly 100,000 annual VTE-related deaths. While it is the most preventable cause of death in hospitalized patients, its incidence will continue to rise with the aging population and as people live longer with chronic conditions.
In this CME Outfitters BriefCase you will meet Walter, a 71-year-old African-American male who presents to his primary care physician's office with swelling in his right leg. Expert faculty will assess the common comorbidities and discuss applying anticoagulant strategies that reflect randomized controlled trials (RCTs), real-world data, and individual patient characteristics.
At the end of this CE activity, participants should be able to:
- Assess common comorbidities in patients requiring anticoagulants.
- Apply anticoagulant strategies to the care of patients that reflect RCTs, real-world data, and individual patient characteristics.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify common comorbidities in patients requiring anticoagulants.
- Summarize anticoagulant strategies for the care of patients that reflect RCTs, real-world data, and individual patient characteristics.
Supported by educational grants from the Bristol Myers Squibb and Pfizer Alliance and Janssen Pharmaceuticals, Inc. administered by Janssen Scientific Affairs, LLC.
VTE specialists, pulmonologists, hematologist-oncologists, emergency physicians, internists, family practitioners, PAs, nurse practitioners, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hours (0.075 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
Note to PAs: PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Piazza reports that he receives grants from Amgen Inc.; Bayer; Bristol Myers Squibb and Pfizer Alliance; Boston Scientific Corporation; Janssen Pharmaceuticals, Inc.; and Portola Pharmaceuticals, Inc.
Dr. Barnes reports that he receives grants from Agency for Healthcare Research and Quality (AHRQ); Blue Cross Blue Shield of Michigan and National Heart, Lung, and Blood Institute (NHLBI). He is a consultant for Acelis Connected Health; AMAG Pharmaceuticals; Bristol Myers Squibb and Pfizer Alliance and Janssen Pharmaceuticals, Inc. He receives other financial or material support as a member of the Board of Directors - Anticoagulation Forum and National Certification Board of Anticoagulation Providers.
Warren Beckman (planning committee) has no disclosures to report.
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).